Abstract
AbstractSeroepidemiology and genomics are valuable tools to investigate the transmission of COVID-19. We utilized qRT-PCR, serum antibody immunoassays, and whole genome sequencing to examine the spread of SARS-CoV-2 infections in North East (NE) region of India during the first and second pandemic waves (June 2020 to September 2021). qRT-PCR analysis was performed on a selected population from NE India during June 2020 to July 2021, and metadata were collected for the region. Seroprevalence and neutralizing antibody immunoassay were studied on selected individuals (n=2026) at three time points (August 2020, February 2021 and June 2021), as well as in a cohort (n=35) for a year (August 2020 to August 2021). SARS-CoV-2 genomes of 914 qRT-PCR positive samples (June 2020 to September 2021) were sequenced and assembled, and those obtained from the sequence databases were analyzed. Test positivity rates in first and second waves were 6.34% and 6.64% in the state of Assam, respectively, and a similar pattern was observed in other NE states. Seropositivity in August 2020, February 2021, and June 2021 were 10.63%, 40.3% and 46.33% respectively, and neutralizing antibody prevalence were 90.91%, 52.14%, and 69.30% respectively. The cohort group showed the presence of stable neutralizing antibody throughout the year. Normal variants dominated the first wave, while the variant of concerns (VOCs) B.1.617.2 and AY-sublineages dominated the second wave, and identified mostly among vaccinated individuals. All eight states of NE India reported numerous incidences of SARS-CoV-2 VOCs, especially B.1.617.2 and AY sublineages, and their prevalence co-related well with high TPR and seropositivity rate in the region. High infection and seroprevalence of COVID-19 in NE India during the second wave was associated with the emergence of VOCs. Natural infection prior to vaccination provided higher neutralizing activity than vaccination alone.
Publisher
Cold Spring Harbor Laboratory
Reference28 articles.
1. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey;The Lancet Global health,2021
2. Genome sequencing by INSACOG shows variants of concern and a novel variant in India, Ministry of Health and Family Welfare, Govt. of India. Available at: https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1707177. Accessed 15 October 2021.
3. Indian SARS-CoV-2 Genomics Consortium (INSACOG), Ministry of Health and Family Welfare, Department of Biotechnology (DBT), Council for Scientific & Industrial Research (CSIR) and Indian Council of Medical Research (ICMR). Available at: https://dbtindia.gov.in/insacog. Accessed 15 October 2021.
4. Accelerating genomics-based surveillance for COVID-19 response in Africa;The Lancet Microbe,2020
5. Indian COVID-19 Genome Surveillance, Department of Biotechnology (DBT), Govt. of India. Available at: http://clingen.igib.res.in/covid19genomes/. Accessed 15 October 2021.